Stevens Capital Management’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Stevens Capital Management’s Portfolio BDSI Stock Details BDSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-14,221	Closed	-$149K	–	1411
2015 Q1	$149K	Buy	+14,221	New	+$194K	0.01%	892
2014 Q3	–	Sell	-10,089	Closed	-$122K	–	1458
2014 Q2	$122K	Buy	+10,089	New	+$95.7K	﹤0.01%	991

Other funds holding BDSI

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

EAM

EverPoint Asset Management Stamford, Connecticut $5.38B AUM 21.45% 1-Year Est. Return

ORI

Oak Ridge Investments Chicago, Illinois $1.51B AUM 37.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

PCM

Penn Capital Management Philadelphia, Pennsylvania $1.29B AUM 53.44% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Stevens Capital Management's BDSI Position: Q2 2015 in Review

Stevens Capital Management sold out of BioDelivery Sciences International, Inc. (BDSI) in Q2 2015, closing a stake of 14,221 shares — an estimated $149K sold.

Stevens Capital Management first reported a position in BDSI in Q2 2014 and held it in 2 quarters. The position peaked at $149K in Q1 2015. 143 funds tracked by Wall St. Rank hold BDSI as of Q2 2015.

Stevens Capital Management reported no remaining BioDelivery Sciences International, Inc. position as of Q2 2015 after selling out during the quarter.
Stevens Capital Management sold 14,221 BioDelivery Sciences International, Inc. shares in Q2 2015, an estimated $149K.
Stevens Capital Management first reported a position in BioDelivery Sciences International, Inc. in Q2 2014 and held it in 2 quarters.
Stevens Capital Management's BioDelivery Sciences International, Inc. position peaked at $149K in Q1 2015.
143 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q2 2015.

Based on Stevens Capital Management's 13F filing for Q2 2015, filed 11 Aug 2015.